Infinion Biopharma Ltd.
Infinion Biopharma Limited is a public company, founded on 16 Jan 2018. This company focuses on innovation that blends biophysics, engineering, classical pharmacology, and biochemistry to generate high-value products across a range of therapeutic areas. A total of 45 lakh equity shares with a face value of Rs. 10 will be sold as part of the Initial public offering.
Purpose of the Issue
- To meet working capital requirement
- Using this fund to invest in Mobius Biomedical Inc.
- Acquire licenses in women’s health products and skin care for product development
Infinion Biopharma Ltd. Financial details
|
Particulars (in Rs.crores) |
FY21 |
FY20 |
FY19 |
|
Total Assets |
18.30 |
8.69 |
7.58 |
|
Share Capital |
10.45 |
9.99 |
7.55 |
|
Total Borrowings |
0.00 |
0.30 |
0.37 |
|
Profit After Tax |
64,240.27 |
13,697.46 |
3,635.15 |
IPO Details
|
IPO Open and Close Date |
To be announced |
|
Listing At |
NSE, BSE |
|
Allotment Date |
To be announced |
|
IPO Listing Date |
To be announced |
|
Initiation of Refunds |
To be announced |
|
The credit of shares to Demat Account |
To be announced |
